TEM slides over 4% as stock trades below key support after bearish earnings and acquisition news

Traders Union
All News
Stocks
Tempus AI drops 4.04% to $42.50 today

Highlights

Tempus AI grew Q2 2026 revenue by 22% to $382.5 million and raised full-year guidance to $1.595–$1.605 billion.
The company announced a $1.5–$1.7 billion debt-financed acquisition of Personalis to broaden cancer genomics and molecular diagnostics capabilities.
Shares remain under sustained selling pressure as bearish momentum and oversold technical signals dominate, with price expected to range between $40.69 and $45.63.

Revenue growth and M&A expansion outpaced by persistent selling pressure

Tempus AI reported Q2 2026 revenue of $382.5 million, marking a 22% increase year-over-year, and posted a net income of $5.6 million for the period. The company recorded positive adjusted EBITDA of $8 million and raised its full-year 2026 revenue guidance to $1.595–$1.605 billion. In July 2026, Tempus AI announced an agreement to acquire Personalis, a cancer genomics company, in a deal valued between $1.5 and $1.7 billion to enhance its capabilities in minimal residual disease testing. The acquisition will be financed primarily through debt, and it is intended to strengthen the company's molecular diagnostics platform, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees pronounced weakness in Tempus AI's structure. He highlights that the breakout below all key moving averages, poor momentum readings, and broad selling after the Personalis acquisition point to persistent downside risk. The fundamentals offer little relief given the size of debt funding for the deal and skepticism surrounding guidance upgrades during a period of heavy selling. Kharitonov cautions that repeated failure to hold support and overwhelmingly bearish sentiment leave limited room for optimism in the near term. "The technical picture is bleak and recent news does little to restore confidence — I would stay defensive until buyers return to the tape."

Viktoras Karapetjanc, expert at Traders Union, sees underlying opportunity in Tempus AI's evolving growth story. He notes robust 22% revenue growth, positive net income, and a raised guidance despite temporary market volatility. The Personalis acquisition is a bold step that can unlock scale advantages and extend leadership in diagnostics. Karapetjanc believes that once acquisition overhang subsides, the bullish structure remains intact and further growth is expected. "Investors willing to look beyond current volatility may find attractive setups as the company delivers on its expanded oncology platform."

Jainam Mehta, market strategist, observes a clear technical breakdown but advises watching for mean reversion near oversold levels. He sees the $40.69–$42.58 support band as crucial for short-term direction. Mehta notes that with volatility elevated and major oscillators stretched, tactical contrarians could explore oversold bounce setups if momentum stabilizes. "A sharp recovery above $42.58 could signal a tactical long opportunity, but I would stay nimble and size positions defensively here."

Bearish momentum confirmed as key technical levels break down

Tempus AI is trading below its 20-day ($52.03), 50-day ($51.06), and 200-day ($59.65) moving averages, signaling sustained downside pressure across short-, medium-, and long-term trends. The Ichimoku Kijun ($51.94) also sits well above the current price, confirming resistance and a broadly bearish bias, with the near-term ceiling at $42.58 and key support at the week low of $40.77. Momentum readings are decisively bearish, as both the MACD (-4.24) and Average Directional Index (ADX) at 21.74 forecast further selling activity. The Relative Strength Index (RSI) at 38.65, Commodity Channel Index (CCI) at -91.57, and Bull/Bear Power (BBP) at -2.82 all point to a market that is oversold, and sellers dominate intraday momentum according to BBP. The Awesome Oscillator at -9.31 reinforces the prevailing bearish tone. The daily session showed downside, with the stock last traded at $42.5, slipping $1.79 or 4.04% after opening with an upside gap of 3.39% ($1.5). The price is positioned near session lows, daily volatility is elevated at 7.54%, and the tone remains heavy as sellers retained control following the gap higher.

Previously it was reported that sustained bearish momentum and technical weakness defined Tempus AI's trading action following its Personalis acquisition announcement and new product launch. The current retracement below key averages and intensifying downside signals reinforce this negative outlook, making the $40.69 support level critical to monitor for potential further downside.

Source of Data: TEM Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.